ADVFN US – Market Content Editor
-
Dollar steadies after partial recovery as bond markets ease and rate cut bets persist
The U.S. dollar held steady on Wednesday, regaining some ground after a sell-off in long-term global bonds pressured other major currencies. Heightened fiscal concerns in the U.S., Japan, and other economies have pushed longer-dated bond yields higher, a trend that typically moves inversely to prices. Yields appear to be stabilizing, particularly in Europe, though German…
-
Alphabet Shares Surge After Court Rules Google Can Retain Chrome Browser
Alphabet (NASDAQ:GOOGL) stock jumped nearly 6% in premarket trading Wednesday following a federal judge’s ruling that Google will not be required to divest its popular Chrome web browser as part of remedies in the Justice Department’s landmark antitrust case. Judge Amit Mehta’s decision allows Google to avoid one of the most severe potential penalties after…
-
Zscaler Shares Rise After Q4 Revenue and Outlook Beat Estimates
Zscaler (NASDAQ:ZS) saw shares climb nearly 2% in premarket trading on Wednesday after reporting fiscal fourth-quarter revenue that exceeded Wall Street forecasts and providing a stronger-than-expected outlook for the upcoming quarter. The cloud security firm posted Q4 revenue of $719.2 million, surpassing analysts’ consensus estimate of $706.95 million, though earnings per share reflected a loss…
-
Healthequity Shares Rise Following Strong Q2 Results and Upbeat Guidance
Healthequity Inc (NASDAQ:HQY) shares surged over 3% in premarket trading on Wednesday after the Draper, Utah-based company reported second-quarter results that exceeded Wall Street expectations and provided an optimistic forecast for the full fiscal year. As the largest Health Savings Account (HSA) custodian in the U.S., Healthequity pointed to solid revenue growth, expanding account volumes,…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures, U.S. Futures Mixed as Google Sidesteps Major Antitrust Penalties
U.S. stock futures indicate a mixed start on Wall Street after equities dropped in the previous session. Alphabet avoided the threat of severe sanctions in a high-profile antitrust case, with a federal judge ruling that Google does not need to divest its popular Chrome browser. Meanwhile, investors await the Federal Reserve’s latest economic report, Salesforce…
-
Gold Tops $3,500 Briefly as Fiscal Risks and Trade Tensions Drive Safe-Haven Demand
Gold prices in Asian trading on Wednesday briefly climbed above $3,500 an ounce, hitting record levels as investors sought refuge amid ongoing concerns over global fiscal health and uncertainty around U.S. trade tariffs. However, the dollar’s recovery, fueled by global bond market selloffs, capped further gains in the yellow metal. Spot gold traded at $3,534.61…
-
Oil Holds Near One-Month High as US-Iran Sanctions and OPEC+ Loom
Oil prices stayed near a one-month peak in early Asian trading on Wednesday, following fresh U.S. sanctions on Iran’s oil sector that fueled concerns over tighter supply. Market attention is now turning to the upcoming OPEC+ meeting, where the cartel is expected to maintain current production levels after a series of hikes earlier this year.…
-
U.S. Stocks Close Mostly Lower But Well Off Worst Levels
After initially showing a significant move to the downside, stocks regained some ground over the course of the trading day on Tuesday but remained firmly negative. The major averages all moved notably lower, extending the pullback seen during last Friday’s session. The tech-heavy Nasdaq slumped 175.92 points or 0.8 percent to 21,279.63 but had tumbled…
-
Actelis Networks Stock Jumps After $0.5 Million FAA Contract
Actelis Networks Inc (NASDAQ:ASNS) shares surged 42% Tuesday after the company announced it had secured a $0.5 million contract from the Federal Aviation Administration (FAA) to supply advanced hybrid-fiber networking solutions for the modernization of critical air traffic control systems. The order is part of the FAA’s larger infrastructure upgrade program, following Congress’s approval of…
-
Zymeworks Shares Drop After Halting Development of Cancer Therapy
Zymeworks Inc (NASDAQ:ZYME) stock declined 9.1% in premarket trading Tuesday after the clinical-stage biotech company announced it will voluntarily cease clinical development of ZW171, a T cell engager aimed at treating gynecological, thoracic, and digestive system cancers. The decision followed the completion of the planned cohorts in the dose-escalation phase of the Phase 1 trial…